CHP Australia emphasises consumer safety in submission to allergies and anaphylaxis inquiry
Today Consumer Healthcare Products (CHP) Australia’s submission to the Standing Committee on Health, Aged Care and Sport's inquiry into allergies and anaphylaxis was published.
As the is the industry association representing manufacturers and distributors of consumer healthcare products, which includes nonprescription medicines, CHP Australia sort to provide information and comment on existing medicines safety regulations, responsible labelling practices, improving heath literacy, and the value of access to medicines as it relates to Australians affected by allergy and anaphylaxis.
Our members recognise the unique needs of consumers affected allergy and anaphylaxis, we look forward to collaborating productively with relevant stakeholders throughout this process and beyond.
A link the CHP Australia submission can be found below.